April 30, 2014
1 min read
Save

Ascites, sodium level increased mortality for children awaiting liver transplantation

The presence of ascites and serum sodium variables among pediatric cirrhotic patients reduced survival rates within 90 days after inclusion on a liver transplantation wait list, according to recent study results.

Researchers analyzed 522 patients (mean age, 20.1 months; 56% female) with cirrhosis on a liver transplant wait list between October 2000 and February 2012. Sixty-six percent of patients (n=345) were aged younger than 12 months, and 40% (n=208) of the entire cohort showed ascites. Seventy-nine percent of patients with hyponatremia presented ascites.

Variables measured included: age, sex, diagnosis, presence of ascites, spontaneous bacterial peritonitis, Pediatric Endstage Liver Disease score (PELD) and ratio of serum sodium concentration.

According to Kaplan-Meier survival curves, patients with sodium levels greater than or equal to 135 mEq/L had a higher survival probability rate over 90 days compared with sodium levels less than 130 mEq/L, (P<.001). Patients without ascites had greater survival probability rate, compared with ascites patients (P<.001). Patients with ascites had a mortality rate of 19.7%, compared with 6.4% for those without ascites, 90 days after being listed for a liver transplant.

In multivariate analysis of pre-transplant variables, total bilirubin (HR=2.09; 95% CI, 1.35-3.21), international normalized ratio (HR=9.83; 95% CI, 4.51-21.45), serum sodium levels (HR=0.96; 95% CI, 0.92-0.99), ascites (HR=2.59; 95% CI, 1.44-4.64) and categorized age (0-1 year vs. older) (HR=2.33; 95% CI, 1.11-4.86) were associated with risk for mortality within 90 days.

“The presence of ascites and serum sodium concentration are important variables associated with decreased patient survival while candidates wait for a liver graft,” researchers concluded. “Further prospective multicenter studies are necessary to validate these findings in order to improve current allocation polices based on the PELD score.”

Disclosure: See the study for a full list of relevant financial disclosures.